FI972780A0 - Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon - Google Patents

Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon

Info

Publication number
FI972780A0
FI972780A0 FI972780A FI972780A FI972780A0 FI 972780 A0 FI972780 A0 FI 972780A0 FI 972780 A FI972780 A FI 972780A FI 972780 A FI972780 A FI 972780A FI 972780 A0 FI972780 A0 FI 972780A0
Authority
FI
Finland
Prior art keywords
malonialdehyde
methional
apoptosis
affects
factor
Prior art date
Application number
FI972780A
Other languages
English (en)
Swedish (sv)
Other versions
FI972780A7 (fi
FI972780L (fi
Inventor
Gerard Anthony Quash
Alain Doutheau
Original Assignee
Rech Dermatologieques Galderma
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Rech Dermatologieques Galderma filed Critical Rech Dermatologieques Galderma
Publication of FI972780A7 publication Critical patent/FI972780A7/fi
Publication of FI972780A0 publication Critical patent/FI972780A0/fi
Publication of FI972780L publication Critical patent/FI972780L/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/11—Aldehydes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Cosmetics (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI972780A 1994-12-29 1995-12-22 Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon FI972780L (fi)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9415884A FR2728790B1 (fr) 1994-12-29 1994-12-29 Composition modulant l'apoptose comprenant du methonial ou tout facteur influencant le taux intracellulaire de methonial
PCT/FR1995/001715 WO1996020701A1 (fr) 1994-12-29 1995-12-22 Composition modulant l'apoptose comprenant un facteur influençant le taux intracellulaire de methional ou de malondialdehyde

Publications (3)

Publication Number Publication Date
FI972780A7 FI972780A7 (fi) 1997-06-27
FI972780A0 true FI972780A0 (fi) 1997-06-27
FI972780L FI972780L (fi) 1997-06-27

Family

ID=9470424

Family Applications (1)

Application Number Title Priority Date Filing Date
FI972780A FI972780L (fi) 1994-12-29 1995-12-22 Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon

Country Status (24)

Country Link
US (1) US5744499A (fi)
EP (1) EP0723778B1 (fi)
JP (1) JP2000515845A (fi)
KR (1) KR100310499B1 (fi)
AR (1) AR001783A1 (fi)
AT (1) ATE191339T1 (fi)
AU (1) AU704064B2 (fi)
BR (1) BR9510509A (fi)
CA (1) CA2166243C (fi)
DE (1) DE69516107T2 (fi)
DK (1) DK0723778T3 (fi)
ES (1) ES2147272T3 (fi)
FI (1) FI972780L (fi)
FR (1) FR2728790B1 (fi)
GR (1) GR3033732T3 (fi)
HU (1) HUT77490A (fi)
IL (1) IL116586A0 (fi)
NO (1) NO973034L (fi)
NZ (1) NZ298831A (fi)
PL (1) PL182597B1 (fi)
PT (1) PT723778E (fi)
RU (1) RU2160103C2 (fi)
WO (1) WO1996020701A1 (fi)
ZA (1) ZA9511015B (fi)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9517622D0 (en) * 1995-08-29 1995-11-01 Univ Edinburgh Regulation of intracellular glucocorticoid concentrations
FR2761606B1 (fr) * 1997-04-08 1999-05-14 Cird Galderma Utilisation de derives aminothiolesters dans le domaine pharmaceutique
US8541469B2 (en) * 1997-08-23 2013-09-24 Glaxo Group Limited Treatment of cell-mediated immune diseases
EP0908179A1 (en) * 1997-08-23 1999-04-14 Werner Bollag Treatment of cell-mediated immune diseases
US6761876B2 (en) * 1998-12-01 2004-07-13 Phylonix Pharmaceuticals, Inc. Methods for introducing helterologous cells into fish
WO1999042606A1 (en) 1998-02-23 1999-08-26 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US6656449B1 (en) * 1998-02-23 2003-12-02 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
US7951989B2 (en) * 1998-02-23 2011-05-31 Phylonix Pharmaceuticals, Inc. Methods of screening agents for activity using teleosts
CN1154484C (zh) * 1998-03-16 2004-06-23 萨默塞特药品有限公司 司来吉兰或去甲基司吉兰在生产治疗创伤、烧伤、光照损害的药物中的用途
FR2777001B1 (fr) 1998-04-01 2000-06-09 Cird Galderma Derives de l'acide 6,8-dimercaptooctanoique substitues en 6-s et/ou en 8-s par le radical (3-methylthiopropanoyl) et compositions pharmaceutiques destinees au traitement des tumeurs cancereuses
TW544310B (en) 1998-04-02 2003-08-01 Ajinomoto Kk Amino acid derivatives and anti-inflammatory agents
AU1784301A (en) * 1999-11-24 2001-06-04 Alticor Inc. Topical skin composition
EP1246617B1 (en) * 1999-12-06 2006-09-13 Rhode Island Hospital Use of taurolidine or taurultam for the manufacture of a medicament for the treatment of ovarian cancer
US20080124409A1 (en) * 2000-11-21 2008-05-29 Access Business Group International Llc Topical Skin Compositions, Their Preparation, and Their Use
US20070003536A1 (en) * 2000-11-21 2007-01-04 Zimmerman Amy C Topical skin compositions, their preparation, and their use
JP2004532245A (ja) * 2001-05-15 2004-10-21 ページ ダブル フォーク 癌を治療するための生体影響性化合物の標的送達
US20030129262A1 (en) * 2001-08-30 2003-07-10 Epner Daniel E. Methionine restriction for cancer therapy
US20030143645A1 (en) * 2001-09-14 2003-07-31 Haystead Timothy A. Quinone reductase 2 and aldehyde dehydrogenase as therapeutic targets
JP2004020220A (ja) * 2002-06-12 2004-01-22 Pioneer Electronic Corp 通信システム及び方法、通信端末装置、通信センタ装置、並びにコンピュータプログラム
WO2005041944A2 (en) * 2003-06-27 2005-05-12 Schepens Eye Research Institute Methods and compositions for promoting axon regeneration and cell replacement therapy
WO2009144253A1 (en) * 2008-05-29 2009-12-03 Karolinska Institutet Innovations Ab Compounds comprising a 3-pyridinol or 5-pyrimidinol ring having an organoseleno or organotelluro substituent for use as antioxidants
SE537517C2 (sv) 2012-12-14 2015-05-26 Stora Enso Oyj Våtlagt arkmaterial innefattande mikrofibrillerad cellulosasamt förfarande för tillverkning därav
WO2017005910A1 (en) * 2015-07-09 2017-01-12 Metabolic Explorer Methionine hydroxy analog (mha) pathways for production by fermentation

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5716898A (en) * 1980-07-03 1982-01-28 Kureha Chem Ind Co Ltd Prostaglandin controller containing aminobenzoic derivative
SU1537247A1 (ru) * 1980-08-21 1990-01-23 Московский научно-исследовательский институт глазных болезней им.Гельмгольца Антигеморрагическое средство "Эмоксипин" дл рассасывани внутриглазных кровоизли ний
SU1375259A1 (ru) * 1983-02-11 1988-02-23 Институт Химической Физики Ан Ссср Фотопротектор дл лечени ожогов сетчатой оболочки глаза
HU201240B (en) * 1987-03-18 1990-10-28 Caola Kozmetikai Cosmetical composition for regeneration of skin
FR2673530B1 (fr) * 1991-03-06 1995-05-19 Monique Moreau Extraits de feuilles de murier, antiradicalaires et antimalondialdehyde.

Also Published As

Publication number Publication date
IL116586A0 (en) 1996-03-31
KR100310499B1 (ko) 2001-12-12
FI972780A7 (fi) 1997-06-27
FR2728790B1 (fr) 1997-01-24
BR9510509A (pt) 1998-07-07
DE69516107D1 (de) 2000-05-11
FR2728790A1 (fr) 1996-07-05
FI972780L (fi) 1997-06-27
CA2166243A1 (fr) 1996-06-30
MX9704491A (es) 1997-10-31
DE69516107T2 (de) 2000-11-16
NZ298831A (en) 2001-04-27
ZA9511015B (en) 1996-08-12
RU2160103C2 (ru) 2000-12-10
JP2000515845A (ja) 2000-11-28
EP0723778A1 (fr) 1996-07-31
ATE191339T1 (de) 2000-04-15
PL320963A1 (en) 1997-11-24
NO973034D0 (no) 1997-06-27
US5744499A (en) 1998-04-28
ES2147272T3 (es) 2000-09-01
GR3033732T3 (en) 2000-10-31
AU4451296A (en) 1996-07-24
WO1996020701A1 (fr) 1996-07-11
NO973034L (no) 1997-08-29
HUT77490A (hu) 1998-05-28
AR001783A1 (es) 1997-12-10
EP0723778B1 (fr) 2000-04-05
KR970706807A (ko) 1997-12-01
AU704064B2 (en) 1999-04-15
PT723778E (pt) 2000-09-29
PL182597B1 (pl) 2002-02-28
DK0723778T3 (da) 2000-07-10
CA2166243C (fr) 2003-07-01

Similar Documents

Publication Publication Date Title
FI972780A0 (fi) Apoptoosia muuntava koostumus, joka sisältää tekijän, joka vaikuttaa metionaalin ja malonidialdehydin solunsisäiseen tasoon
FI944310A7 (fi) Heteroaryyliamino- ja heteroaryylisuolfonamidosubstituoituja 3-bentsyyliaminometyylipiperidiinejä ja vastaavia yhdisteitä
FI961720A0 (fi) Uusi koostumus
FI932103A7 (fi) Uusia 4-aryylipiperatsiineja ja 4-aryylipiperidiinejä
FI952179A7 (fi) Uusia 3,3-difenyylipropyyliamiineja, niiden käyttö ja valmistus
FI945281A7 (fi) Heterosykliset yhdisteet, niiden valmistus ja käyttö
FI944624A0 (fi) 4-aryyliaminobentsopyraani- ja niiden kaltaisia yhdisteitä
FI935728A7 (fi) Substituoituja 4-fenyylipyridoneja ja 4-fenyyli-2-alkoksipyridiinejä
DE69119031D1 (de) Diarylmethoxypiperidin-Derivate
FI954229L (fi) Heterosykliset yhdisteet, niiden käyttö ja valmistus
FI930716A7 (fi) Uusia aryylikarbonyyliaminoalkyylidihydro-oksopyridiinejä, niiden valmistus ja käyttö
FI971462A0 (fi) Bentsisoksatsolijohdannaisia ja niitä sisältäviä torjuntaainekoostumuksia
DE69225990D1 (de) Lichtempfindliche Bistrihalomethyl-s-triazin-Verbindung und photopolymerisierbare Zusammensetzung, dieselbe enthaltend
FI931502L (fi) Ny pyretroidkomposition
DE3854130D1 (de) Applikator und dessen verpackung.
FI942331L (fi) Biosidisia koostumuksia ja niiden käyttö
FI952855L (fi) Uudet triatsolokinatsoliinit, niiden valmistus ja käyttö
DE69216238D1 (de) Autoschmelzbares dämpfungsmaterial
FI913836A7 (fi) Biosidisia yhdisteitä ja niiden käyttö
DK88093D0 (da) Stabilt praeparat
BR9200689A (pt) Composicao profilatica
FI945716A7 (fi) Uusi selegiliiniä sisältävä valmiste
NO944631D0 (no) Sammensetning inneholdende selegilin
SE9301471L (sv) Ny beredning
DK113992D0 (da) Ny murerbalje

Legal Events

Date Code Title Description
MA Patent expired